Skip to content

News & Press

Meridian Bioscience Expands Production Capacity in Ohio

Published: Tue Feb 16 2021
We are excited to be in the final stages of bringing the Revogene SARS-CoV-2 assay to market. Our customers continue to search for more tests to battle this wave of the coronavirus pandemic and this support from our federal, state, and local governments will be instrumental in scaling our manufacturing capacity.
Tony Serafini-Lamanna -
executive vice president of Diagnostics, Meridian Bioscience